$30.81 0.80 (+2.67%)
11/25/2009 2:24 PM

Medivation, Inc. (MDVN)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

Featured Broker Partners